Profil
Sara Blum Sherman is currently working as Vice President-Investor Relations at Exscientia AI Ltd. and Exscientia Plc.
She previously worked as Senior Director-Investor Relations & Strategy at DBV Technologies SA from 2016 to 2020 and as Head-Investor Relations at UroGen Pharma Ltd.
Aktive Positionen von Sara Blum Sherman
| Unternehmen | Position | Beginn |
|---|---|---|
| EXSCIENTIA PLC | Investor Relations Kontakt | 01.08.2021 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Sara Blum Sherman
| Unternehmen | Position | Ende |
|---|---|---|
| UROGEN PHARMA LTD. | Investor Relations Kontakt | 01.08.2021 |
| DBV TECHNOLOGIES | Public Communications Contact | 01.09.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
UroGen Pharma Ltd.
UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
















